BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29797241)

  • 21. CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma.
    Shang Y; He J; Wang Y; Feng Q; Zhang Y; Guo J; Li J; Li S; Wang Y; Yan G; Ren F; Shi Y; Xu J; Zeps N; Zhai Y; He D; Chang Z
    Oncogene; 2017 Jul; 36(29):4191-4200. PubMed ID: 28346425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interdependence of GLO I and PKM2 in the Metabolic shift to escape apoptosis in GLO I-dependent cancer cells.
    Shimada N; Takasawa R; Tanuma SI
    Arch Biochem Biophys; 2018 Jan; 638():1-7. PubMed ID: 29225125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Novel mechanism for invasion and metastasis involving metabolic enzymes in intractable cancer cells].
    Konno M; Hamabe A; Doki Y; Mori M; Ishii H
    Rinsho Ketsueki; 2015 Aug; 56(8):1059-63. PubMed ID: 26345567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.
    Tang R; Yang C; Ma X; Wang Y; Luo D; Huang C; Xu Z; Liu P; Yang L
    Oncotarget; 2016 Feb; 7(5):5972-84. PubMed ID: 26745603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase.
    Yacovan A; Ozeri R; Kehat T; Mirilashvili S; Sherman D; Aizikovich A; Shitrit A; Ben-Zeev E; Schutz N; Bohana-Kashtan O; Konson A; Behar V; Becker OM
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6460-8. PubMed ID: 22963766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor M2-PK: A novel urine marker of bladder cancer.
    Liu W; Woolbright BL; Pirani K; Didde R; Abbott E; Kaushik G; Martin P; Hamilton-Reeves J; Taylor JA; Holzbeierlein JM; Anant S; Lee EK
    PLoS One; 2019; 14(6):e0218737. PubMed ID: 31246990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PKM2 Thr454 phosphorylation increases its nuclear translocation and promotes xenograft tumor growth in A549 human lung cancer cells.
    Yu Z; Huang L; Qiao P; Jiang A; Wang L; Yang T; Tang S; Zhang W; Ren C
    Biochem Biophys Res Commun; 2016 May; 473(4):953-958. PubMed ID: 27045080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activators of PKM2 in cancer metabolism.
    Warner SL; Carpenter KJ; Bearss DJ
    Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the diverse role of pyruvate kinase M2 in cancer: Navigating beyond glycolysis and the Warburg effect.
    Upadhyay S; Khan S; Hassan MI
    Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189089. PubMed ID: 38458358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HSP40 interacts with pyruvate kinase M2 and regulates glycolysis and cell proliferation in tumor cells.
    Huang L; Yu Z; Zhang T; Zhao X; Huang G
    PLoS One; 2014; 9(3):e92949. PubMed ID: 24658033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
    Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
    Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma.
    Li C; Zhao Z; Zhou Z; Liu R
    Dig Dis Sci; 2016 Mar; 61(3):767-73. PubMed ID: 26500118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
    Vander Heiden MG; Locasale JW; Swanson KD; Sharfi H; Heffron GJ; Amador-Noguez D; Christofk HR; Wagner G; Rabinowitz JD; Asara JM; Cantley LC
    Science; 2010 Sep; 329(5998):1492-9. PubMed ID: 20847263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moderate DNA damage promotes metabolic flux into PPP via PKM2 Y-105 phosphorylation: a feature that favours cancer cells.
    Kumar B; Bamezai RN
    Mol Biol Rep; 2015 Aug; 42(8):1317-21. PubMed ID: 25840825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppressed "Warburg Effect" in Nasopharyngeal Carcinoma Via the Inhibition of Pyruvate Kinase Type M2-Mediated Energy Generation Pathway.
    Zhao P; Zhou M; Chen R; Su R
    Technol Cancer Res Treat; 2020; 19():1533033820945804. PubMed ID: 32815467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of PKM2 in Lgr5
    Kim Y; Lee YS; Kang SW; Kim S; Kim TY; Lee SH; Hwang SW; Kim J; Kim EN; Ju JS; Park YY; Kweon MN
    Sci Rep; 2019 Apr; 9(1):6212. PubMed ID: 30996297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA VAL facilitates PKM2 enzymatic activity to promote glycolysis and malignancy of gastric cancer.
    Dai T; Zhang X; Zhou X; Hu X; Huang X; Xing F; Tian H; Li Y
    Clin Transl Med; 2022 Oct; 12(10):e1088. PubMed ID: 36229913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Metabolism enzyme controls cancer stemness].
    Konno M; Doki Y; Mori M; Ishii H
    Nihon Rinsho; 2015 May; 73(5):745-50. PubMed ID: 25985625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Warburg Effect Mediator Pyruvate Kinase M2 Expression and Regulation in the Retina.
    Rajala RV; Rajala A; Kooker C; Wang Y; Anderson RE
    Sci Rep; 2016 Nov; 6():37727. PubMed ID: 27883057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant overexpression of pyruvate kinase M2 is associated with aggressive tumor features and the BRAF mutation in papillary thyroid cancer.
    Feng C; Gao Y; Wang C; Yu X; Zhang W; Guan H; Shan Z; Teng W
    J Clin Endocrinol Metab; 2013 Sep; 98(9):E1524-33. PubMed ID: 23846818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.